These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Growth hormone treatment of short children born small for gestational age].
    Author: Christesen HB, Jensen RB, Birkebaek NH, Hertel NT, Main KM, Mortensen HB, Naeraa RW, Juul A.
    Journal: Ugeskr Laeger; 2006 Feb 27; 168(9):889-95. PubMed ID: 16513050.
    Abstract:
    Short children born small for gestational age (SGA) are defined as having a birth weight below -2 SD for gestational age and a reduced height at four years of age (height < -2.5 SD). Growth hormone (GH) treatment significantly improves final height (mean height gain 12 centimetres) in such children. Consequently, GH therapy has been an approved indication in Europe since 2003 for SGA children who remain short at four years of age. The Danish consensus guidelines for diagnosis, treatment and control of short SGA children are described in this review.
    [Abstract] [Full Text] [Related] [New Search]